Aurora Cannabis (ACB) Retained Earnings (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Retained Earnings of -$4.7 billion for Q1 2026, down 4340.03% year-on-year from $110.8 million in Q1 2025, and down 2.28% on a QoQ basis from -$4.6 billion in Q4 2025.

Aurora Cannabis (ACB) Retained Earnings (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Retained Earnings for 9 consecutive years, with -$4.7 billion the latest figure, recorded in Q1 2026.

  • Quarterly Retained Earnings fell 4340.03% year-over-year to -$4.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.7 billion (down 4340.03% YoY) and the FY2026 annual result came in at -$4.7 billion, down 4176.23% from the prior year.
  • Retained Earnings declined to -$4.7 billion in Q1 2026 per ACB's latest filing, from -$4.6 billion in the prior quarter.
  • Over the last five years, Retained Earnings for ACB reached as high as $120.5 million in Q1 2024 and fell as low as -$4.7 billion in Q2 2022.
  • A 5-year average of -$4.1 billion and a median of -$4.7 billion in 2025 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2024 — Retained Earnings jumped 102.59% — and 2026, when it tumbled 4340.03%.
  • Year by year, Retained Earnings stood at -$4.6 billion in 2022, then decreased by 2.13% to -$4.7 billion in 2023, then gained by 2.69% to -$4.6 billion in 2024, then declined by 0.9% to -$4.6 billion in 2025, then slipped by 2.28% to -$4.7 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$4.7 billion, -$4.6 billion, and -$4.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -4.70 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.70 Bn
Dec 31, 2025 -4.59 Bn
Sep 30, 2025 -4.65 Bn
Jun 30, 2025 -4.61 Bn
Mar 31, 2025 110.79 Mn
Dec 31, 2024 -4.55 Bn
Sep 30, 2024 -4.68 Bn
Jun 30, 2024 -4.66 Bn
Mar 31, 2024 120.48 Mn
Dec 31, 2023 -4.68 Bn
Sep 30, 2023 -4.73 Bn
Jun 30, 2023 -4.71 Bn
Mar 31, 2023 -4.65 Bn
Dec 31, 2022 -4.58 Bn
Sep 30, 2022 -4.72 Bn
Jun 30, 2022 -4.73 Bn
Mar 31, 2022 -4.28 Bn
Dec 31, 2021 -3.50 Bn
Sep 30, 2021 -3.44 Bn
Jun 30, 2021 115.11 Mn